Co-morbidities

Rishi Sethi , Pravesh Vishwakarma , Akshyaya Pradhan

Read time: 19m 41s

Aleksandra Bykova , Maria Serova , Maria Chashkina , et al

Read time: 22m 11s
ESC 24: MRAs in Heart Failure

Watch time: 5m 46s

Biykem Bozkurt, Muthiah Vaduganathan, , et al

Watch time: 1h 1m 12s
Timing of Cardio-Kidney Protection with SGLT2 Inhibitors

Radcliffe Cardiology, Karen Bell; Special Editor: Greg Guillory

Giulio Balestrieri , Raul Limonta , Enrico Ponti , et al

Read time: 18m 10s

Vijay Chopra, Deepak L Bhatt, George L Bakris, et al

Ileana L Piña, Gianluigi Savarese, , et al

Ileana L Piña, Gianluigi Savarese, , et al

AHA 23 Late-Breaker Discussion: The DAPA-MI Trial

Harriette Van Spall, Stefan James

Watch time: 14m 14s
2023 ESC Guidelines Update: Acute & Chronic Heart Failure

Giuseppe Rosano, Harriette Van Spall

Watch time: 10m 8s

Simran Singh Parmar , Vasantha Muthuppalaniappan , Debasish Banerjee

Read time: 5m

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)

Muthiah Vaduganathan

Andrew JS Coats, Stefan Anker

David K Ryan , Debasish Banerjee , Fadi Jouhra

Read time: 10m
Effects of Dapagliflozin in Patients With Chronic Kidney Disease, With and Without Heart Failure

John JV McMurray

Watch time: 6m 48s

James Burton, Shelley Zieroth, Andrew Frankel et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Giulio Balestrieri , Raul Limonta , Enrico Ponti , et al

Read time: 18m 10s

Biykem Bozkurt, Muthiah Vaduganathan, , et al

Watch time: 1h 1m 12s

About

Comorbidities frequently accompany chronic heart failure, contributing to increased morbidity and mortality, and an impaired quality of life. Extreme comorbidity is significantly more common in patients with chronic heart failure due to left ventricular systolic dysfunction. The efficient management of such complexity requires the integration of general and specialist expertise.

Media

HFA 23: DAPA MODA: Dapaglifozin & Cardiac Remodelling in Chronic HF

Domingo Figal

Watch time: 8m 47s

James Burton, Shelley Zieroth, Andrew Frankel et al

Watch time: 1h 34m (7 videos)

Fausto J Pinto, John Spertus et al

ACC 23 Late-breaking Discussion: The COORDINATE-Diabetes Trial

Harriette Van Spall, Neha Pagidipati, Christopher B Granger, et al

Watch time: 17m 32s

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Stefan Anker, Javed Butler, Shelley Zieroth, et al

Shelley Zieroth

Watch time: 3m 59s (1 video)

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)
ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s

Andrew JS Coats, Stefan Anker

Media

Biykem Bozkurt, Muthiah Vaduganathan, , et al

Watch time: 1h 1m 12s

Andrew JS Coats, Stefan Anker

Shelley Zieroth, Andrew Frankel, James Burton, et al

Watch time: 1h 34m 52s

Muthiah Vaduganathan

ACC 22 Late-breaker Discussion: The DIAMOND Trial

Harriette Van Spall, Javed Butler, Faiez Zannad, et al

Watch time: 22m 47s
ESC 22: EMPEROR-POOLED: Clinical Benefits of SGLT2i in Heart Failure

Faiez Zannad

Watch time: 4m 44s

Carolyn Lam, Scott Solomon, John JV McMurray, et al

Watch time: 1:02:16 (5 videos)
ESC 22: EMPEROR-Preserved & DELIVER Meta-Analysis: SGLT2is in HF

Muthiah Vaduganathan

Watch time: 5m 1s
AHA 22: Efficacy of Empagliflozin in Black vs White Pts With Heart Failure

Subodh Verma

Watch time: 5m

Shelley Zieroth

Watch time: 3m 59s (1 video)

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Articles

SGLT2i in HFpEF

Mauro Gori

,

Emilia D’Elia

,

Edoardo Sciatti

,

Michele Senni

,

Published:

08 July 2022

Citation:

Cardiac Failure Review 2022;8:e26.

DOI:

https://doi.org/10.15420/cfr.2022.04
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 3276
  • Downloads: Downloads 278
  • Citations: 3
  • Read time: 10m

APSC Consensus on OSA in CVD Patients

Jack Wei Chieh Tan

,

Leong Chai Leow

,

Serene Wong

,

See Meng Khoo

,

Takatoshi Kasai

,

Pipin Kojodjojo

,

Duong-Quy Sy

,

Chuen Peng Lee

,

Naricha Chirakalwasan

,

Hsueh-Yu Li

,

Natalie Koh

,

Adeline Tan

,

Thun How Ong

,

Aye Thandar Aung

,

Song Tar Toh

,

Chi-Hang Lee

,

Published:

20 June 2022

Citation:

European Cardiology Review 2022;17:e16.

DOI:

https://doi.org/10.15420/ecr.2021.59
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1862
  • Downloads: Downloads 83
  • Citations: 2
  • Read time: 15m

Diabetes in Stage C Heart Failure

Anjali Agarwalla

,

Jadry Gruen

,

Carli Peters

,

Lauren Sinnenberg

,

Anjali T Owens

,

Nosheen Reza

,

Published:

28 March 2022

Citation:

Cardiac Failure Review 2022;8:e10.

DOI:

https://doi.org/10.15420/cfr.2021.31
Permissions× For commercial reprint enquiries please contact Springer Healthcare: ReprintsWarehouse@springernature.com.

For permissions and non-commercial reprint enquiries, please visit Copyright.com to start a request.

For author reprints, please email rob.barclay@radcliffe-group.com.
  • Views: Views 1409
  • Downloads: Downloads 148
  • Read time: 11m